Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation.

Journal:

Journal of Clinical Oncology

Published:

2025-06-17

DOI:

10.1200/jco-25-00856

Affiliations:

19

Authors:

33

Go to article

Institutions	Authors	Share
Center for International Blood Marrow Transplant Research (CIBMTR), United States of America (USA)	18.000000 18.000000	0.55
Medical College of Wisconsin (MCW), United States of America (USA)	1.500000	0.05
University of Pennsylvania (Penn), United States of America (USA)	1.000000	0.03
UVA Health System, United States of America (USA)	1.000000	0.03
Oregon Health and Science University (OHSU), United States of America (USA)	1.000000	0.03
University of Miami (UM), United States of America (USA)	1.000000	0.03
H. Lee Moffitt Cancer Center & Research Institute, United States of America (USA)	1.000000	0.03
OSU Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James), United States of America (USA)	1.000000	0.03
City of Hope, United States of America (USA)	1.000000	0.03
Dana-Farber Cancer Institute (DFCI), United States of America (USA)	1.000000	0.03
Stanford Health Care, United States of America (USA)	1.000000	0.03
University of Michigan (U-M), United States of America (USA)	1.000000	0.03
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)	1.000000	0.03
Barbara Ann Karmanos Cancer Institute, Wayne State University, United States of America (USA)	1.000000	0.03
Emory University, United States of America (USA)	0.500000	0.02
Children's Healthcare of Atlanta (CHOA) Inc., United States of America (USA)	0.500000	0.02
Qatar University, Qatar	0.500000	0.02

Interested in Immunology?